Kejal Kantarci on CMS Plans to Limit Aduhelm Coverage to Clinical Trials
COMMENT the way for future amyloid modifying treatments. kantarci.kejal 0
8 RESULTS
COMMENT the way for future amyloid modifying treatments. kantarci.kejal 0
COMMENT involvement of regions outside of the medial temporal lobe. kantarci.kejal 0
COMMENT kantarci.kejal 0 AV-1451 tau and β-amyloid positron emission tomography imaging in dementia with Lewy bodies.
COMMENT dementias, and not hard to obtain. kantarci.kejal 0
COMMENT for making treatment decisions based on amyloid PET scans. kantarci.kejal 0
COMMENT diseases is critical for multitarget treatment strategies in these disorders. kantarci.kejal 0
COMMENT autopsy confirmation. kantarci.kejal 0
COMMENT 0 kantarci.kejal Focal hemosiderin deposits and β-amyloid load in the ADNI cohort.